Wu Tingting, Liu Yajing, Wang Shuman, Shi Chen
Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, Hubei, People's Republic of China.
Int J Nanomedicine. 2025 Jun 21;20:7953-7974. doi: 10.2147/IJN.S525394. eCollection 2025.
Mesenchymal stem cells (MSCs) are pluripotent stem cells that have great potential in the field of regenerative medicine. Extracellular vesicles that derived from MSCs inherit the bioactive molecules, including lipids, proteins, nucleic acids, from the donate cells. With similar biological functions as MSCs, MSC-EVs show lower toxicity, better biocompatibility, stability, and less immune rejection. Therefore, MSC-EVs are emerging as a cell-free alternative therapy for MSC-based cell therapy. Here, we reviewed the characteristics of different subtype of MSC-EVs, the functional molecules in MSC-EVs for tissue repair, the potential applications of MSC-EVs for different tissue injuries in recent three years, and the clinical progress as well as the existing challenges in MSC-EV based therapy. This review would provide some insights for the future researches and clinical translation of MSC-EVs in regenerative medicine.
间充质干细胞(MSCs)是多能干细胞,在再生医学领域具有巨大潜力。源自间充质干细胞的细胞外囊泡继承了供体细胞的生物活性分子,包括脂质、蛋白质、核酸。间充质干细胞衍生的细胞外囊泡(MSC-EVs)具有与间充质干细胞相似的生物学功能,显示出较低的毒性、更好的生物相容性、稳定性和较少的免疫排斥反应。因此,MSC-EVs正作为基于间充质干细胞的细胞疗法的无细胞替代疗法而兴起。在此,我们综述了不同亚型MSC-EVs的特征、MSC-EVs中用于组织修复的功能分子、近三年来MSC-EVs在不同组织损伤中的潜在应用、临床进展以及基于MSC-EV疗法的现有挑战。本综述将为MSC-EVs在再生医学中的未来研究和临床转化提供一些见解。